Magnolia Market Access provides tailored strategies and insights to pharmaceutical companies, device manufacturers, and trade associations to meet their market access, HEOR, and healthcare policy needs. We have broadened the definition of Market Access beyond getting the right treatment to the right patient at the right time. Our Market Access strategies and solutions begin in early product development, leading your organization to a successful approval and launch. In a dynamic and uncertain reimbursement environment, we help your organization focus on the four “Ps”, Payers, Providers, Patients, and Policymakers.
Clients rely on us to provide 360-degree perspectives and spotlight data to shape policy, communicate value, secure reimbursement, and drive patient access. Using our in-house or client specified clinical and real-world data we spotlight the results in a compelling way to shape policy, communicate value, secure reimbursement, and drive patient access. Clients can expect us to keep them apprised of any proposed or enacted legislation and conversations with regulators and legislators. Magnolia Market Access works with you to maximize access from the earliest stages of development through patent expiration and beyond.